Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy

NCT02166593 is registered in ClinicalTrials.gov with Yooyoung Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02166593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02166593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy and Safety of Pravastatin/Fenofibrate Complex in Patients With Combined Dyslipidemia With Adequately Controlled LDL-C But Inadequately Controlled Triglyceride Level by Atorvastatin Monotherapy
Lead sponsor
Yooyoung Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2014
Completion date
January 31, 2018
Enrollment
302 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

combined dyslipidemia